We analyzed by pyrosequencing nine CpG-dinucleotides in intron 2 of FKBP5 that were implicated in metabolic disorders in previous studies and flanked an experimentally validated GRE [8, 11]. This evidence concerns the gene FKBP5 and metabolic disease.